Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition
Clinical trial NCT00224016 · COMPLETED
Trial details
- NCT number
- NCT00224016
- Sponsor
- Watson Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2007-04-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.